指南与共识流行病学与生物统计

妊娠期高血压疾病的筛查:美国预防服务工作组最终推荐声明

Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.
指南 / 共识 · JAMA · 2023-01-01

美国预防服务工作组(USPSTF)基于系统综述评估妊娠期高血压疾病筛查的利弊,结论为中等确定性、净获益显著,推荐在整个孕期用血压测量筛查妊娠期高血压疾病(B级推荐)。

要点

  • USPSTF推荐在整个孕期用血压测量筛查妊娠期高血压疾病(B级推荐)。
  • 目标人群为无已知妊娠期高血压疾病或慢性高血压诊断的孕妇。
  • 筛查净获益为中等确定性(moderate certainty),净获益显著。

核心结论

  • USPSTF以中等确定性得出结论:用血压测量筛查妊娠期高血压疾病具有显著净获益。

研究设计与样本

  • USPSTF委托的系统综述评估妊娠期高血压疾病筛查的获益与危害。

主要发现

  • 妊娠期高血压疾病发病率从1993年约每10000次分娩500例上升至2016至2017年每10000次分娩1021例。

关键数值与推荐

  • USPSTF推荐在整个孕期用血压测量筛查孕妇的妊娠期高血压疾病(B级推荐)。

临床怎么用

  • 对无已知妊娠期高血压疾病或慢性高血压诊断的孕妇,在整个孕期用血压测量进行筛查(B级推荐)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017. OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. POPULATION: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. RECOMMENDATION: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Barry MJ, Nicholson WK, Silverstein M, et al. Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement. JAMA. 2023. PMID: 37721605. doi:10.1001/jama.2023.16991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。